Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell membrane is a critical structural component of prokaryotic cells, serving as a selective barrier and a site for essential processes such as oxidative phosphorylation and nutrient transport (Epand et al., 2016, PubMed). In the context of dermatology, this membrane exists within the skin surface microenvironment, which is characterized by a specific pH range (4.7–5.7), moisture levels, and a complex community of commensal microorganisms known as the microbiome (Grice & Segre, 2011, Nature Reviews Microbiology). Therapeutic strategies often target the bacterial membrane using antimicrobial peptides or lipopeptides that induce pore formation or membrane depolarization, leading to rapid cell death (StatPearls, Polymyxin B). Simultaneously, the skin microenvironment influences the efficacy and stability of these drugs, as factors like pH and sebum composition can alter drug ionization and penetration (Ali & Yosipovitch, 2013, PubMed). Disruptions in the balance of this microenvironment are linked to various conditions, including acne, atopic dermatitis, and chronic wound infections. Understanding the interplay between the bacterial membrane and the cutaneous environment is essential for developing effective topical treatments that selectively eliminate pathogens while preserving host tissue and beneficial flora. This entry is marked as incorrect because it combines a specific cellular structure with a broad physiological environment rather than identifying a single molecular target.
Disruption of bacterial lipid bilayer integrity, induction of pore formation, membrane depolarization, and modulation of the skin surface pH to inhibit pathogenic growth.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane and skin surface microenvironment.